A Cochrane systematic review of 22 randomized trials involving 1,995 adults with overweight or obesity found intermittent ...

PHILADELPHIA -- At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a ...

A decade-long commitment to medically supervised care, advanced wellness therapies, and personalized health solutions ...

Dr. Joseph Moleski of STL Med Weight Loss reveals a cutting-edge, affordable telemedicine approach using GLP-1 treatments.

Ozempic may be more expensive and harder to find now that compounded semaglutide isn't available. Here are 9 reputable places ...

Weight loss platform Elevate Now has raised ₹18 crore in seed funding, led by Physis Capital, with participation from ...

MEDVi has a physician-monitored telehealth platform that enables patients to receive GLP-1 weight loss therapy through linking with licensed clinicians, compounded drugs via licensed pharmacies and ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context, published pricing disclosures, telehealth ...

For years, Patricia Williamson struggled with weight loss. “I’d been on and off WeightWatchers for 30 years,” the 75-year-old Setauket resident said. “I lost weight on WeightWatchers but I could never ...

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...